Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

SNYR vs MCK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MCK Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

MCK Overall Winner 6-Pillar Tally: SNYR 2 – 4 MCK Matrix Metrics: SNYR 3 – 7 MCK

As of Nov 20, 2026, McKesson Corporation (MCK) is the stronger overall head-to-head candidate over Synergy CHC Corp. (SNYR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SNYR carries a Unified Composite Score of 48.9/100 (HOLD) at $0.09 (0.6x Forward P/E, -10.3% operating margin), whereas MCK carries 43.1/100 (HOLD) at $1,069.43 (24.2x Forward P/E, 1.6% operating margin).

  • Composite vs. Pillar Nuance: While SNYR currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. MCK 43.1/100 HOLD), MCK captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (1.6% vs. -10.3% operating margin) and revenue trajectory (+7.6% vs. -32.8% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SNYR vs MCK
SNYR NASDAQ
Synergy CHC Corp. Common Stock
Medicinal Chemicals & Botanical Products
$0.09
-67.02% 1D
Market Cap $4.1M
TTM Revenue $28M
Forward P/E 0.6x
Beta / 30D Vol -0.86β · 868% Vol
Unified Composite Score
48.9 / 100 HOLD
Tech 55.0 Fund 39.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.3 · SMA20: $0.11 · SMA50: $0.14
MCK NYSE Head-to-Head Winner
McKesson Corporation
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$1,069.43
+0.68% 1D
Market Cap $122.6B
TTM Revenue $418.8B
Forward P/E 24.2x
Beta / 30D Vol -0.22β · 32% Vol
Unified Composite Score
43.1 / 100 HOLD
Tech 22.0 Fund 35.0 Flow 57.0 Mom 25.9
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.1% over 20 days), RSI 60
RSI-14: 60.4 · SMA20: $1,045.53 · SMA50: $974.32

6-Pillar Scorecard Institutional Category Breakdown (SNYR 2 – 4 MCK)

Columns: Metric · SNYR · MCK
1. Valuation Multiples SNYR
Forward P/E 0.6x 24.2x
Trailing P/E 0.6x 27.4x
PEG Ratio N/M 1.87x
EV / Revenue 0.1x 0.3x
2. Growth & Scale MCK
Revenue Growth (YoY) -32.8% +7.6%
Earnings Growth (YoY) -90.6% +17.0%
TTM Revenue (USD) $28M $418.8B
Market Cap $4.1M $122.6B
3. Profitability & Quality MCK
Gross Margin 65.4% 3.7%
Operating Margin -10.3% 1.6%
Net Profit Margin -57.0% 1.1%
Return on Equity (ROE) -361.1% 0.0%
4. Balance Sheet & Cash Flow MCK
Cash Generation (TTM) -$3.8M $6.87B
Cash Flow Margin -13.7% 1.6%
Net Cash / Leverage -361.1% ROE $4.63B Net Debt
Dividend Yield None (0.00%) 0.31%
5. Options & Positioning MCK
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile N/A (N/A) 26.5% (5th %ile)
Put/Call OI Skew N/A 0.24x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat SNYR
OpEx & R&D Intensity 75.7% of Rev ($21M) 2.1% of Rev ($8.79B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Distribution Operator Medical Distribution Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SNYR (3) vs MCK (7)
Institutional Metric SNYR MCK Criterion Row Edge
Market Capitalization
Scale
$4.1M $122.6B Larger Scale MCK
Trailing P/E Ratio
Valuation
0.6x 27.4x Lower Multiple SNYR
Forward P/E Ratio
Valuation
0.6x 24.2x Lower Multiple SNYR
Revenue Growth (YoY)
Growth
-32.8% +7.6% Higher Growth MCK
Operating Margin (TTM)
Profitability
-10.3% 1.6% Higher Margin MCK
Net Profit Margin
Profitability
-57.0% 1.1% Higher Margin MCK
Return on Equity (ROE)
Capital Efficiency
-361.1% 0.0% Higher ROE MCK
52-Week Range Position
Momentum
1% ($0–$3) 87% ($724–$1,122) Stronger Trend MCK
Beta / 30D Volatility
Risk Regime
-0.86β · 868% Vol -0.22β · 32% Vol Lower Realized Risk MCK
Unified Institutional Score
Composite Signal
48.9 / 100 (HOLD) 43.1 / 100 (HOLD) Higher Composite SNYR
Trailing 12M Revenue (USD)
Operating Scale
$28M $418.8B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
65.4% 3.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev 1.87x PEG · 0.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$3.8M (-361.1% ROE) $6.87B ($4.63B Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MCK +17.47 pp
SNYR: -16.28% · MCK: +1.19%
3M Horizon MCK +69.43 pp
SNYR: -56.64% · MCK: +12.79%
6M Horizon MCK +88.77 pp
SNYR: -93.2% · MCK: -4.43%
1Y Horizon MCK +99.31 pp
SNYR: -96.13% · MCK: +3.18%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period SNYR Revenue MCK Revenue SNYR Op. Margin MCK Op. Margin Margin Leader
FY2019 $30M $214.3B -27.1% 0.4% MCK
FY2020 N/A $231.1B N/A 1.1% MCK
FY2021 N/A $238.2B N/A -2.1% MCK
FY2022 N/A $264.0B N/A 0.8% MCK
FY2023 $40M $276.7B 25.3% 1.6% SNYR
FY2024 $30M $308.9B 16.7% 1.3% SNYR
FY2025 $30M $359.1B -27.8% 1.2% MCK
FY2026 N/A $403.4B N/A 1.5% MCK

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SNYR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SNYR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MCK SURGE
5d in phase · OBV NEUTRAL
Current IV 26.5%
IV Percentile 5th %ile
Put/Call OI Skew 0.24x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact MCK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $1,059.10 · IV 27.2%

MCK Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($105,910)

Compare $105,910 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 27.2% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $1,060 / $1,100 Bull Call Spread

Buy 1x $1,060C · Sell 1x $1,100C · 29d

Net Entry $330 Debit
T+5d @ +5% Move +$1,265 (+383%)
Max Risk / Buffer $330 Capped
5d Edge & Liquidity 2.5x R:R · Liq C
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Dec 18 $1,000 / $950 Bull Put Spread

Sell 1x $1,000P · Buy 1x $950P · 29d

Net Entry $930 Credit
Max Credit / Yield +$930 (+22.9% RoM)
Max Risk / Buffer -6.5% Cushion ($4,070 Mgn)
5d Edge & Liquidity 77% PoP · Liq C
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq C

Dec 18 $1,000P / $1,060-$1,120C Seagull

Sell 1x $1,000P · Buy 1x $1,060/$1,120C · 29d

Net Entry $278 Credit
T+5d @ +5% Move +$2,612 (+16.1% RoM)
Max Risk / Buffer -5.6% Put Cushion ($16,244 Mgn)
5d Edge & Liquidity 0.9x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SNYR Moat Profile Cyclical / Execution-Driven Positioning
Medical Distribution Operator
Competes within the Medical Distribution value chain with $4.1M market capitalization and -10.3% operating margin.
OpEx & R&D Reinvestment 75.7% of Rev ($21M)
90D Engineering Disclosures 0 Published
MCK Moat Profile Cyclical / Execution-Driven Positioning
Medical Distribution Operator
Competes within the Medical Distribution value chain with $122.6B market capitalization and 1.6% operating margin.
OpEx & R&D Reinvestment 2.1% of Rev ($8.79B)
90D Engineering Disclosures 0 Published

Investor FAQ SNYR vs MCK Key Questions & Quantitative Answers

As of Nov 20, 2026, McKesson Corporation (MCK) is the stronger overall head-to-head candidate over Synergy CHC Corp. (SNYR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SNYR carries a Unified Composite Score of 48.9/100 (HOLD) at $0.09 (0.6x Forward P/E, -10.3% operating margin), whereas MCK carries 43.1/100 (HOLD) at $1,069.43 (24.2x Forward P/E, 1.6% operating margin). Composite vs. Pillar Nuance: While SNYR currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. MCK 43.1/100 HOLD), MCK captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (1.6% vs. -10.3% operating margin) and revenue trajectory (+7.6% vs. -32.8% YoY).

MCK leads the Growth & Scale pillar: SNYR posts -32.8% YoY revenue growth and -90.6% YoY earnings growth on $28M TTM revenue (65.4% gross margin, -10.3% operating margin), compared with MCK at +7.6% YoY revenue growth and +17.0% YoY earnings growth on $418.8B TTM revenue (3.7% gross margin, 1.6% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), SNYR cumulative revenue shifted +0.0% while MCK shifted +88.2%. In operating R&D and SG&A reinvestment, SNYR deploys 75.7% of Rev ($21M) (0 90-day corporate R&D disclosures) versus 2.1% of Rev ($8.79B) (0 disclosures) for MCK.

SNYR screens cheaper on headline valuation multiples. SNYR trades at 0.6x Forward P/E, 0.6x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% FCF margin), whereas MCK trades at 24.2x Forward P/E, 27.4x Trailing P/E, 1.87x PEG, and 0.3x EV/Revenue (1.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SNYR (-361.1% ROE) versus MCK (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, SNYR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.86β · 868% Vol realized risk). By comparison, MCK carries 26.5% implied volatility (5th %ile, Compressed (<25th %ile)), a 0.24x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (-0.22β · 32% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.